| Min Pa: | Min Pa(max): | Activity's type: |
| Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |
|---|---|---|---|---|---|---|
| 0.988 | 0.001 | 0.988 | Androgen antagonist | 0.979 0.001 DBMET02920 0.885 0.002 DBMET02923 0.978 0.001 DBMET02926 0.894 0.002 DBMET02929 0.894 0.002 DBMET02930 0.96 0.002 DBMET02931 0.853 0.002 DBMET02921 0.937 0.002 DBMET02922 0.645 0.003 DBMET02925 0.645 0.003 DBMET02924 0.846 0.002 DBMET02927 0.846 0.002 DBMET02928 0.783 0.002 DBMET02932 0.791 0.002 DBMET02933 0.791 0.002 DBMET02934 | ||
| 0.982 | 0.004 | 0.984 | Antiinflammatory | 0.978 0.004 DBMET02920 0.977 0.004 DBMET02923 0.979 0.004 DBMET02926 0.964 0.004 DBMET02929 0.964 0.004 DBMET02930 0.981 0.004 DBMET02931 0.952 0.004 DBMET02921 0.976 0.004 DBMET02922 0.948 0.004 DBMET02925 0.948 0.004 DBMET02924 0.953 0.004 DBMET02927 0.953 0.004 DBMET02928 0.984 0.004 DBMET02932 0.957 0.004 DBMET02933 0.957 0.004 DBMET02934 | DBMET02932 | |
| 0.973 | 0.002 | 0.973 | Hypoxia-inducible factor 1 alpha inhibitor | 0.904 0.002 DBMET02920 0.835 0.003 DBMET02923 0.95 0.002 DBMET02926 0.844 0.003 DBMET02929 0.844 0.003 DBMET02930 0.936 0.002 DBMET02931 0.768 0.004 DBMET02921 0.851 0.003 DBMET02922 0.708 0.004 DBMET02925 0.708 0.004 DBMET02924 0.81 0.003 DBMET02927 0.81 0.003 DBMET02928 0.952 0.002 DBMET02932 0.798 0.003 DBMET02933 0.798 0.003 DBMET02934 | ||
| 0.957 | 0.001 | 0.957 | Androgen agonist | 0.87 0.001 DBMET02920 0.607 0.002 DBMET02923 0.763 0.001 DBMET02926 0.938 0.001 DBMET02929 0.938 0.001 DBMET02930 0.885 0.001 DBMET02931 0.845 0.001 DBMET02921 0.76 0.001 DBMET02922 0.571 0.002 DBMET02925 0.571 0.002 DBMET02924 0.717 0.001 DBMET02927 0.717 0.001 DBMET02928 0.865 0.001 DBMET02932 0.88 0.001 DBMET02933 0.88 0.001 DBMET02934 | ||
| 0.944 | 0.001 | 0.944 | Antipruritic | 0.88 0.002 DBMET02920 0.728 0.003 DBMET02923 0.827 0.002 DBMET02926 0.767 0.003 DBMET02929 0.767 0.003 DBMET02930 0.891 0.002 DBMET02931 0.629 0.004 DBMET02921 0.812 0.002 DBMET02922 0.363 0.008 DBMET02925 0.363 0.008 DBMET02924 0.507 0.004 DBMET02927 0.507 0.004 DBMET02928 0.886 0.002 DBMET02932 0.657 0.003 DBMET02933 0.657 0.003 DBMET02934 | ||
| 0.916 | 0.005 | 0.919 | Transcription factor NF kappa B inhibitor | 0.888 0.007 DBMET02920 0.892 0.007 DBMET02923 0.883 0.007 DBMET02926 0.833 0.011 DBMET02929 0.833 0.011 DBMET02930 0.887 0.007 DBMET02931 0.766 0.015 DBMET02921 0.846 0.01 DBMET02922 0.776 0.014 DBMET02925 0.776 0.014 DBMET02924 0.755 0.016 DBMET02927 0.755 0.016 DBMET02928 0.919 0.005 DBMET02932 0.777 0.014 DBMET02933 0.777 0.014 DBMET02934 | DBMET02932 | |
| 0.882 | 0.004 | 0.884 | Toll-Like receptor 7 agonist | 0.861 0.005 DBMET02920 0.829 0.005 DBMET02923 0.884 0.004 DBMET02926 0.856 0.005 DBMET02929 0.856 0.005 DBMET02930 0.833 0.005 DBMET02931 0.831 0.005 DBMET02921 0.798 0.005 DBMET02922 0.784 0.005 DBMET02925 0.784 0.005 DBMET02924 0.858 0.005 DBMET02927 0.858 0.005 DBMET02928 0.759 0.006 DBMET02932 0.785 0.005 DBMET02933 0.785 0.005 DBMET02934 | DBMET02926 | |
| 0.88 | 0.005 | 0.882 | Toll-Like receptor agonist | 0.859 0.005 DBMET02920 0.825 0.005 DBMET02923 0.882 0.004 DBMET02926 0.856 0.005 DBMET02929 0.856 0.005 DBMET02930 0.829 0.005 DBMET02931 0.831 0.005 DBMET02921 0.794 0.005 DBMET02922 0.783 0.005 DBMET02925 0.783 0.005 DBMET02924 0.858 0.005 DBMET02927 0.858 0.005 DBMET02928 0.752 0.006 DBMET02932 0.785 0.005 DBMET02933 0.785 0.005 DBMET02934 | DBMET02926 | |
| 0.859 | 0 | 0.86 | Transcortin receptor antagonist | 0.706 0 DBMET02920 0.666 0 DBMET02923 0.46 0 DBMET02926 0.245 0 DBMET02929 0.245 0 DBMET02930 0.777 0 DBMET02931 0.078 0 DBMET02921 0.459 0 DBMET02922 0.069 0.001 DBMET02925 0.069 0.001 DBMET02924 0.045 0.001 DBMET02927 0.045 0.001 DBMET02928 0.86 0 DBMET02932 0.155 0 DBMET02933 0.155 0 DBMET02934 | DBMET02932 | |
| 0.826 | 0.002 | 0.887 | Aromatase inhibitor | 0.687 0.002 DBMET02920 0.58 0.003 DBMET02923 0.752 0.002 DBMET02926 0.553 0.003 DBMET02929 0.553 0.003 DBMET02930 0.887 0.001 DBMET02931 0.36 0.004 DBMET02921 0.759 0.002 DBMET02922 0.238 0.007 DBMET02925 0.238 0.007 DBMET02924 0.45 0.004 DBMET02927 0.45 0.004 DBMET02928 0.757 0.002 DBMET02932 0.63 0.002 DBMET02933 0.63 0.002 DBMET02934 | DBMET02931 | |
| 0.811 | 0.001 | 0.811 | Progesterone antagonist | 0.761 0.001 DBMET02920 0.711 0.001 DBMET02923 0.697 0.002 DBMET02926 0.587 0.002 DBMET02929 0.587 0.002 DBMET02930 0.62 0.002 DBMET02931 0.508 0.002 DBMET02921 0.544 0.002 DBMET02922 0.428 0.003 DBMET02925 0.428 0.003 DBMET02924 0.409 0.003 DBMET02927 0.409 0.003 DBMET02928 0.346 0.003 DBMET02932 0.337 0.003 DBMET02933 0.337 0.003 DBMET02934 | ||
| 0.789 | 0.001 | 0.789 | Glucocorticoid agonist | 0.765 0.001 DBMET02920 0.755 0.001 DBMET02923 0.769 0.001 DBMET02926 0.604 0.001 DBMET02929 0.604 0.001 DBMET02930 0.767 0.001 DBMET02931 0.5 0.001 DBMET02921 0.733 0.001 DBMET02922 0.442 0.001 DBMET02925 0.442 0.001 DBMET02924 0.492 0.001 DBMET02927 0.492 0.001 DBMET02928 0.747 0.001 DBMET02932 0.458 0.001 DBMET02933 0.458 0.001 DBMET02934 | ||
| 0.78 | 0.004 | 0.783 | Immunosuppressant | 0.752 0.004 DBMET02920 0.727 0.005 DBMET02923 0.75 0.004 DBMET02926 0.783 0.004 DBMET02929 0.783 0.004 DBMET02930 0.755 0.004 DBMET02931 0.756 0.004 DBMET02921 0.722 0.005 DBMET02922 0.732 0.004 DBMET02925 0.732 0.004 DBMET02924 0.755 0.004 DBMET02927 0.755 0.004 DBMET02928 0.746 0.004 DBMET02932 0.757 0.004 DBMET02933 0.757 0.004 DBMET02934 | DBMET02930 | |
| 0.752 | 0.001 | 0.752 | Glucocorticoid antagonist | 0.615 0.002 DBMET02920 0.672 0.001 DBMET02923 0.661 0.001 DBMET02926 0.439 0.002 DBMET02929 0.439 0.002 DBMET02930 0.625 0.002 DBMET02931 0.352 0.002 DBMET02921 0.499 0.002 DBMET02922 0.377 0.002 DBMET02925 0.377 0.002 DBMET02924 0.37 0.002 DBMET02927 0.37 0.002 DBMET02928 0.478 0.002 DBMET02932 0.331 0.002 DBMET02933 0.331 0.002 DBMET02934 | ||
| 0.758 | 0.022 | 0.763 | Apoptosis agonist | 0.712 0.029 DBMET02920 0.727 0.026 DBMET02923 0.741 0.024 DBMET02926 0.692 0.032 DBMET02929 0.692 0.032 DBMET02930 0.763 0.021 DBMET02931 0.642 0.041 DBMET02921 0.716 0.028 DBMET02922 0.654 0.038 DBMET02925 0.654 0.038 DBMET02924 0.671 0.035 DBMET02927 0.671 0.035 DBMET02928 0.757 0.022 DBMET02932 0.691 0.032 DBMET02933 0.691 0.032 DBMET02934 | DBMET02931 | |
| 0.665 | 0.001 | 0.697 | Lipocortins synthesis antagonist | 0.651 0.002 DBMET02920 0.685 0.001 DBMET02923 0.697 0.001 DBMET02926 0.655 0.002 DBMET02929 0.655 0.002 DBMET02930 0.569 0.003 DBMET02931 0.641 0.002 DBMET02921 0.555 0.003 DBMET02922 0.674 0.001 DBMET02925 0.674 0.001 DBMET02924 0.685 0.001 DBMET02927 0.685 0.001 DBMET02928 0.537 0.003 DBMET02932 0.554 0.003 DBMET02933 0.554 0.003 DBMET02934 | DBMET02926 | |
| 0.661 | 0.001 | 0.661 | Interferon gamma antagonist | 0.648 0.002 DBMET02920 0.653 0.001 DBMET02923 0.624 0.002 DBMET02926 0.6 0.002 DBMET02929 0.6 0.002 DBMET02930 0.641 0.002 DBMET02931 0.587 0.003 DBMET02921 0.629 0.002 DBMET02922 0.592 0.003 DBMET02925 0.592 0.003 DBMET02924 0.562 0.003 DBMET02927 0.562 0.003 DBMET02928 0.594 0.003 DBMET02932 0.585 0.003 DBMET02933 0.585 0.003 DBMET02934 | ||
| 0.618 | 0.004 | 0.618 | Interleukin 6 antagonist | 0.54 0.004 DBMET02920 0.605 0.004 DBMET02923 0.472 0.005 DBMET02926 0.466 0.005 DBMET02929 0.466 0.005 DBMET02930 0.55 0.004 DBMET02931 0.393 0.008 DBMET02921 0.459 0.005 DBMET02922 0.444 0.005 DBMET02925 0.444 0.005 DBMET02924 0.3 0.015 DBMET02927 0.3 0.015 DBMET02928 0.444 0.005 DBMET02932 0.386 0.008 DBMET02933 0.386 0.008 DBMET02934 | ||
| 0.611 | 0 | 0.611 | Arachidonic acid antagonist | 0.45 0 DBMET02920 0.411 0 DBMET02923 0.414 0 DBMET02926 0.403 0 DBMET02929 0.403 0 DBMET02930 0.51 0 DBMET02931 0.348 0.001 DBMET02921 0.415 0 DBMET02922 0.328 0.001 DBMET02925 0.328 0.001 DBMET02924 0.33 0.001 DBMET02927 0.33 0.001 DBMET02928 0.576 0 DBMET02932 0.383 0 DBMET02933 0.383 0 DBMET02934 | ||
| 0.579 | 0.011 | 0.728 | Nitric oxide antagonist | 0.537 0.013 DBMET02920 0.523 0.014 DBMET02923 0.536 0.013 DBMET02926 0.534 0.013 DBMET02929 0.534 0.013 DBMET02930 0.7 0.006 DBMET02931 0.495 0.016 DBMET02921 0.651 0.007 DBMET02922 0.48 0.017 DBMET02925 0.48 0.017 DBMET02924 0.492 0.016 DBMET02927 0.492 0.016 DBMET02928 0.728 0.005 DBMET02932 0.647 0.008 DBMET02933 0.647 0.008 DBMET02934 | DBMET02932 | |
| 0.568 | 0.009 | 0.611 | DNA synthesis inhibitor | 0.611 0.007 DBMET02920 0.537 0.011 DBMET02923 0.556 0.01 DBMET02926 0.49 0.014 DBMET02929 0.49 0.014 DBMET02930 0.461 0.016 DBMET02931 0.531 0.011 DBMET02921 0.504 0.013 DBMET02922 0.451 0.017 DBMET02925 0.451 0.017 DBMET02924 0.476 0.015 DBMET02927 0.476 0.015 DBMET02928 0.429 0.019 DBMET02932 0.377 0.025 DBMET02933 0.377 0.025 DBMET02934 | DBMET02920 | |
| 0.552 | 0.001 | 0.741 | Anabolic | 0.328 0.001 DBMET02920 0.295 0.001 DBMET02923 0.363 0.001 DBMET02926 0.741 0.001 DBMET02929 0.741 0.001 DBMET02930 0.388 0.001 DBMET02931 0.379 0.001 DBMET02921 0.272 0.001 DBMET02922 0.333 0.001 DBMET02925 0.333 0.001 DBMET02924 0.427 0.001 DBMET02927 0.427 0.001 DBMET02928 0.396 0.001 DBMET02932 0.522 0.001 DBMET02933 0.522 0.001 DBMET02934 | DBMET02930 | |
| 0.523 | 0.002 | 0.523 | Aldosterone antagonist | 0.404 0.002 DBMET02920 0.458 0.002 DBMET02923 0.498 0.002 DBMET02926 0.35 0.003 DBMET02929 0.35 0.003 DBMET02930 0.284 0.003 DBMET02931 0.22 0.004 DBMET02921 0.179 0.004 DBMET02922 0.28 0.003 DBMET02925 0.28 0.003 DBMET02924 0.325 0.003 DBMET02927 0.325 0.003 DBMET02928 0.166 0.005 DBMET02932 0.15 0.005 DBMET02933 0.15 0.005 DBMET02934 | ||
| 0.523 | 0.007 | 0.618 | P-glycoprotein inhibitor | 0.484 0.009 DBMET02920 0.566 0.005 DBMET02923 0.618 0.005 DBMET02926 0.271 0.035 DBMET02929 0.271 0.035 DBMET02930 0.47 0.01 DBMET02931 0.24 0.045 DBMET02921 0.419 0.014 DBMET02922 0.318 0.026 DBMET02925 0.318 0.026 DBMET02924 0.402 0.016 DBMET02927 0.402 0.016 DBMET02928 0.393 0.017 DBMET02932 0.217 0.054 DBMET02933 0.217 0.054 DBMET02934 | DBMET02926 | |
| 0.535 | 0.028 | 0.59 | Aldehyde oxidase inhibitor | 0.379 0.05 DBMET02920 0.59 0.02 DBMET02923 0.526 0.029 DBMET02926 0.465 0.038 DBMET02929 0.465 0.038 DBMET02930 0.541 0.027 DBMET02931 0.302 0.066 DBMET02921 0.388 0.049 DBMET02922 0.535 0.028 DBMET02925 0.535 0.028 DBMET02924 0.453 0.039 DBMET02927 0.453 0.039 DBMET02928 0.296 0.067 DBMET02932 0.494 0.034 DBMET02933 0.494 0.034 DBMET02934 | DBMET02923 | |
| 0.507 | 0.007 | 0.631 | Diuretic | 0.391 0.013 DBMET02920 0.482 0.008 DBMET02923 0.609 0.005 DBMET02926 0.53 0.006 DBMET02929 0.53 0.006 DBMET02930 0.281 0.026 DBMET02931 0.425 0.012 DBMET02921 0.187 0.05 DBMET02922 0.508 0.007 DBMET02925 0.508 0.007 DBMET02924 0.631 0.004 DBMET02927 0.631 0.004 DBMET02928 0.176 0.056 DBMET02932 0.303 0.022 DBMET02933 0.303 0.022 DBMET02934 | DBMET02928 | |
| 0.499 | 0 | 0.499 | Corticosteroid-like | 0.435 0 DBMET02920 0.416 0 DBMET02923 0.452 0 DBMET02926 0.246 0.001 DBMET02929 0.246 0.001 DBMET02930 0.449 0 DBMET02931 0.202 0.001 DBMET02921 0.374 0.001 DBMET02922 0.179 0.001 DBMET02925 0.179 0.001 DBMET02924 0.205 0.001 DBMET02927 0.205 0.001 DBMET02928 0.288 0.001 DBMET02932 0.188 0.001 DBMET02933 0.188 0.001 DBMET02934 | ||
| 0.492 | 0.02 | 0.492 | Interleukin antagonist | 0.435 0.026 DBMET02920 0.474 0.022 DBMET02923 0.396 0.031 DBMET02926 0.329 0.042 DBMET02929 0.329 0.042 DBMET02930 0.368 0.036 DBMET02931 0.266 0.056 DBMET02921 0.299 0.048 DBMET02922 0.303 0.047 DBMET02925 0.303 0.047 DBMET02924 0.209 0.079 DBMET02927 0.209 0.079 DBMET02928 0.183 0.094 DBMET02932 0.177 0.098 DBMET02933 0.177 0.098 DBMET02934 | ||
| 0.471 | 0.005 | 0.472 | Sodium/bile acid cotransporter inhibitor | 0.464 0.006 DBMET02920 0.471 0.005 DBMET02923 0.465 0.006 DBMET02926 0.472 0.005 DBMET02929 0.472 0.005 DBMET02930 0.427 0.011 DBMET02931 0.465 0.006 DBMET02921 0.42 0.012 DBMET02922 0.471 0.005 DBMET02925 0.471 0.005 DBMET02924 0.465 0.006 DBMET02927 0.465 0.006 DBMET02928 0.437 0.009 DBMET02932 0.429 0.01 DBMET02933 0.429 0.01 DBMET02934 | DBMET02930 | |
| 0.455 | 0 | 0.455 | Lipocortins synthesis agonist | 0.389 0 DBMET02920 0.343 0 DBMET02923 0.339 0 DBMET02926 0.256 0.001 DBMET02929 0.256 0.001 DBMET02930 0.35 0 DBMET02931 0.223 0.001 DBMET02921 0.27 0.001 DBMET02922 0.203 0.001 DBMET02925 0.203 0.001 DBMET02924 0.202 0.001 DBMET02927 0.202 0.001 DBMET02928 0.249 0.001 DBMET02932 0.2 0.001 DBMET02933 0.2 0.001 DBMET02934 | ||
| 0.438 | 0.004 | 0.438 | Interleukin 8 antagonist | 0.274 0.005 DBMET02920 0.407 0.004 DBMET02923 0.269 0.005 DBMET02926 0.231 0.007 DBMET02929 0.231 0.007 DBMET02930 0.183 0.018 DBMET02931 0.165 0.025 DBMET02921 0.125 0.056 DBMET02922 0.219 0.009 DBMET02925 0.219 0.009 DBMET02924 0.162 0.027 DBMET02927 0.162 0.027 DBMET02928 0.101 0.095 DBMET02933 0.101 0.095 DBMET02934 | ||
| 0.435 | 0.002 | 0.442 | 5-Alpha-reductase inhibitor | 0.347 0.003 DBMET02920 0.285 0.003 DBMET02923 0.375 0.002 DBMET02926 0.429 0.002 DBMET02929 0.429 0.002 DBMET02930 0.442 0.002 DBMET02931 0.341 0.003 DBMET02921 0.354 0.002 DBMET02922 0.277 0.004 DBMET02925 0.277 0.004 DBMET02924 0.368 0.002 DBMET02927 0.368 0.002 DBMET02928 0.356 0.002 DBMET02932 0.434 0.002 DBMET02933 0.434 0.002 DBMET02934 | DBMET02931 | |
| 0.408 | 0.004 | 0.411 | Estrogen antagonist | 0.411 0.004 DBMET02920 0.309 0.006 DBMET02923 0.345 0.005 DBMET02926 0.306 0.006 DBMET02929 0.306 0.006 DBMET02930 0.378 0.005 DBMET02931 0.313 0.005 DBMET02921 0.384 0.005 DBMET02922 0.222 0.01 DBMET02925 0.222 0.01 DBMET02924 0.251 0.008 DBMET02927 0.251 0.008 DBMET02928 0.284 0.007 DBMET02932 0.27 0.007 DBMET02933 0.27 0.007 DBMET02934 | DBMET02920 | |
| 0.411 | 0.008 | 0.411 | NOS3 expression enhancer | 0.39 0.009 DBMET02920 0.358 0.011 DBMET02923 0.349 0.012 DBMET02926 0.261 0.024 DBMET02929 0.261 0.024 DBMET02930 0.37 0.01 DBMET02931 0.245 0.027 DBMET02921 0.353 0.011 DBMET02922 0.198 0.042 DBMET02925 0.198 0.042 DBMET02924 0.188 0.046 DBMET02927 0.188 0.046 DBMET02928 0.384 0.009 DBMET02932 0.205 0.039 DBMET02933 0.205 0.039 DBMET02934 | ||
| 0.406 | 0.009 | 0.557 | Lipid peroxidase inhibitor | 0.393 0.01 DBMET02920 0.376 0.011 DBMET02923 0.513 0.005 DBMET02926 0.481 0.006 DBMET02929 0.481 0.006 DBMET02930 0.347 0.013 DBMET02931 0.471 0.006 DBMET02921 0.34 0.014 DBMET02922 0.463 0.007 DBMET02925 0.463 0.007 DBMET02924 0.557 0.004 DBMET02927 0.557 0.004 DBMET02928 0.267 0.024 DBMET02932 0.434 0.008 DBMET02933 0.434 0.008 DBMET02934 | DBMET02928 | |
| 0.398 | 0.003 | 0.412 | Mineralocorticoid receptor antagonist | 0.412 0.003 DBMET02920 0.266 0.004 DBMET02923 0.305 0.004 DBMET02926 0.267 0.004 DBMET02929 0.267 0.004 DBMET02930 0.321 0.004 DBMET02931 0.284 0.004 DBMET02921 0.339 0.004 DBMET02922 0.151 0.005 DBMET02925 0.151 0.005 DBMET02924 0.183 0.004 DBMET02927 0.183 0.004 DBMET02928 0.198 0.004 DBMET02932 0.182 0.004 DBMET02933 0.182 0.004 DBMET02934 | DBMET02920 | |
| 0.384 | 0.053 | 0.578 | Cholesterol antagonist | 0.459 0.039 DBMET02920 0.319 0.08 DBMET02923 0.282 0.103 DBMET02926 0.42 0.046 DBMET02929 0.42 0.046 DBMET02930 0.522 0.029 DBMET02931 0.494 0.034 DBMET02921 0.578 0.021 DBMET02922 0.339 0.069 DBMET02925 0.339 0.069 DBMET02924 0.302 0.09 DBMET02927 0.302 0.09 DBMET02928 0.546 0.026 DBMET02932 0.567 0.023 DBMET02933 0.567 0.023 DBMET02934 | DBMET02922 | |
| 0.329 | 0.005 | 0.329 | Estrogen receptor alpha antagonist | 0.138 0.014 DBMET02920 0.127 0.016 DBMET02923 0.116 0.02 DBMET02926 0.299 0.005 DBMET02929 0.299 0.005 DBMET02930 0.133 0.015 DBMET02931 0.129 0.016 DBMET02921 0.083 0.045 DBMET02922 0.119 0.019 DBMET02925 0.119 0.019 DBMET02924 0.108 0.023 DBMET02927 0.108 0.023 DBMET02928 0.109 0.023 DBMET02932 0.127 0.016 DBMET02933 0.127 0.016 DBMET02934 | ||
| 0.418 | 0.1 | 0.424 | Caspase 9 stimulant | 0.381 0.123 DBMET02920 0.424 0.097 DBMET02923 0.424 0.097 DBMET02926 0.403 0.109 DBMET02929 0.403 0.109 DBMET02930 0.301 0.193 DBMET02931 0.367 0.133 DBMET02921 0.271 0.227 DBMET02922 0.41 0.105 DBMET02925 0.41 0.105 DBMET02924 0.409 0.106 DBMET02927 0.409 0.106 DBMET02928 0.374 0.128 DBMET02932 0.297 0.197 DBMET02933 0.297 0.197 DBMET02934 | DBMET02926 | |
| 0.359 | 0.044 | 0.499 | Antioxidant | 0.34 0.049 DBMET02920 0.388 0.037 DBMET02923 0.369 0.041 DBMET02926 0.468 0.024 DBMET02929 0.468 0.024 DBMET02930 0.344 0.048 DBMET02931 0.446 0.027 DBMET02921 0.324 0.054 DBMET02922 0.499 0.02 DBMET02925 0.499 0.02 DBMET02924 0.48 0.022 DBMET02927 0.48 0.022 DBMET02928 0.356 0.045 DBMET02932 0.458 0.025 DBMET02933 0.458 0.025 DBMET02934 | DBMET02924 | |
| 0.323 | 0.028 | 0.497 | Anesthetic general | 0.246 0.052 DBMET02920 0.264 0.044 DBMET02923 0.228 0.06 DBMET02926 0.217 0.066 DBMET02929 0.217 0.066 DBMET02930 0.494 0.008 DBMET02931 0.153 0.111 DBMET02921 0.409 0.015 DBMET02922 0.167 0.097 DBMET02925 0.167 0.097 DBMET02924 0.139 0.126 DBMET02927 0.139 0.126 DBMET02928 0.497 0.008 DBMET02932 0.384 0.019 DBMET02933 0.384 0.019 DBMET02934 | DBMET02932 | |
| 0.28 | 0.002 | 0.32 | Progesterone agonist | 0.25 0.002 DBMET02920 0.228 0.002 DBMET02923 0.32 0.002 DBMET02926 0.193 0.002 DBMET02929 0.193 0.002 DBMET02930 0.305 0.002 DBMET02931 0.18 0.002 DBMET02921 0.275 0.002 DBMET02922 0.168 0.003 DBMET02925 0.168 0.003 DBMET02924 0.219 0.002 DBMET02927 0.219 0.002 DBMET02928 0.176 0.002 DBMET02932 0.198 0.002 DBMET02933 0.198 0.002 DBMET02934 | DBMET02926 | |
| 0.297 | 0.025 | 0.344 | Glyceraldehyde-3-phosphate dehydrogenase inhibitor | 0.329 0.016 DBMET02920 0.31 0.02 DBMET02923 0.344 0.013 DBMET02926 0.183 0.089 DBMET02929 0.183 0.089 DBMET02930 0.217 0.059 DBMET02921 0.16 0.127 DBMET02922 0.196 0.075 DBMET02925 0.196 0.075 DBMET02924 0.236 0.049 DBMET02927 0.236 0.049 DBMET02928 | DBMET02926 | |
| 0.332 | 0.07 | 0.398 | Immunostimulant | 0.398 0.05 DBMET02920 0.304 0.077 DBMET02923 0.341 0.067 DBMET02926 0.259 0.092 DBMET02929 0.259 0.092 DBMET02930 0.21 0.114 DBMET02931 0.347 0.065 DBMET02921 0.298 0.079 DBMET02922 0.233 0.103 DBMET02925 0.233 0.103 DBMET02924 0.271 0.088 DBMET02927 0.271 0.088 DBMET02928 0.2 0.12 DBMET02932 0.161 0.146 DBMET02933 0.161 0.146 DBMET02934 | DBMET02920 | |
| 0.281 | 0.02 | 0.312 | Topoisomerase II inhibitor | 0.272 0.021 DBMET02920 0.286 0.019 DBMET02923 0.312 0.016 DBMET02926 0.296 0.018 DBMET02931 0.287 0.019 DBMET02922 0.304 0.017 DBMET02932 | DBMET02926 | |
| 0.266 | 0.004 | 0.266 | Interleukin 5 antagonist | 0.24 0.005 DBMET02920 0.24 0.005 DBMET02923 0.224 0.005 DBMET02926 0.184 0.006 DBMET02929 0.184 0.006 DBMET02930 0.185 0.006 DBMET02931 0.174 0.007 DBMET02921 0.174 0.007 DBMET02922 0.171 0.008 DBMET02925 0.171 0.008 DBMET02924 0.162 0.009 DBMET02927 0.162 0.009 DBMET02928 0.171 0.008 DBMET02932 0.135 0.016 DBMET02933 0.135 0.016 DBMET02934 | ||
| 0.328 | 0.067 | 0.349 | Apoptosis antagonist | 0.342 0.059 DBMET02920 0.323 0.071 DBMET02923 0.285 0.096 DBMET02926 0.335 0.063 DBMET02929 0.335 0.063 DBMET02930 0.289 0.093 DBMET02931 0.349 0.056 DBMET02921 0.309 0.08 DBMET02922 0.33 0.066 DBMET02925 0.33 0.066 DBMET02924 0.294 0.089 DBMET02927 0.294 0.089 DBMET02928 0.309 0.079 DBMET02932 0.301 0.085 DBMET02933 0.301 0.085 DBMET02934 | DBMET02921 | |
| 0.282 | 0.024 | 0.315 | Neurotrophic factor enhancer | 0.315 0.014 DBMET02920 0.256 0.035 DBMET02923 0.253 0.037 DBMET02926 0.265 0.031 DBMET02929 0.265 0.031 DBMET02930 0.27 0.028 DBMET02931 0.295 0.019 DBMET02921 0.301 0.018 DBMET02922 0.24 0.045 DBMET02925 0.24 0.045 DBMET02924 0.236 0.047 DBMET02927 0.236 0.047 DBMET02928 0.255 0.036 DBMET02932 0.256 0.035 DBMET02933 0.256 0.035 DBMET02934 | DBMET02920 | |
| 0.269 | 0.012 | 0.342 | Antineoplastic antibiotic | 0.243 0.015 DBMET02920 0.242 0.015 DBMET02923 0.267 0.012 DBMET02926 0.255 0.014 DBMET02929 0.255 0.014 DBMET02930 0.277 0.011 DBMET02931 0.228 0.017 DBMET02921 0.25 0.014 DBMET02922 0.226 0.017 DBMET02925 0.226 0.017 DBMET02924 0.252 0.014 DBMET02927 0.252 0.014 DBMET02928 0.342 0.007 DBMET02932 0.264 0.013 DBMET02933 0.264 0.013 DBMET02934 | DBMET02932 | |
| 0.271 | 0.014 | 0.4 | Alkylator | 0.345 0.01 DBMET02920 0.351 0.01 DBMET02923 0.4 0.008 DBMET02926 0.161 0.041 DBMET02929 0.161 0.041 DBMET02930 0.144 0.05 DBMET02931 0.198 0.027 DBMET02921 0.181 0.032 DBMET02922 0.201 0.026 DBMET02925 0.201 0.026 DBMET02924 0.233 0.019 DBMET02927 0.233 0.019 DBMET02928 0.115 0.073 DBMET02932 | DBMET02926 | |
| 0.248 | 0.006 | 0.304 | Estrogen agonist | 0.282 0.005 DBMET02920 0.19 0.009 DBMET02923 0.128 0.013 DBMET02926 0.239 0.007 DBMET02929 0.239 0.007 DBMET02930 0.267 0.006 DBMET02931 0.274 0.005 DBMET02921 0.304 0.005 DBMET02922 0.185 0.009 DBMET02925 0.185 0.009 DBMET02924 0.123 0.014 DBMET02927 0.123 0.014 DBMET02928 0.237 0.007 DBMET02932 0.255 0.006 DBMET02933 0.255 0.006 DBMET02934 | DBMET02922 | |
| 0.276 | 0.036 | 0.353 | Hepatoprotectant | 0.345 0.02 DBMET02920 0.274 0.037 DBMET02923 0.282 0.035 DBMET02926 0.275 0.037 DBMET02929 0.275 0.037 DBMET02930 0.28 0.035 DBMET02931 0.342 0.02 DBMET02921 0.353 0.019 DBMET02922 0.272 0.038 DBMET02925 0.272 0.038 DBMET02924 0.281 0.035 DBMET02927 0.281 0.035 DBMET02928 0.325 0.024 DBMET02932 0.282 0.035 DBMET02933 0.282 0.035 DBMET02934 | DBMET02922 | |
| 0.256 | 0.017 | 0.341 | Cholesterol synthesis inhibitor | 0.236 0.02 DBMET02920 0.247 0.018 DBMET02923 0.219 0.023 DBMET02926 0.341 0.008 DBMET02929 0.341 0.008 DBMET02930 0.211 0.024 DBMET02931 0.327 0.009 DBMET02921 0.194 0.028 DBMET02922 0.335 0.008 DBMET02925 0.335 0.008 DBMET02924 0.314 0.01 DBMET02927 0.314 0.01 DBMET02928 0.229 0.021 DBMET02932 0.319 0.009 DBMET02933 0.319 0.009 DBMET02934 | DBMET02930 | |
| 0.34 | 0.107 | 0.387 | Antibacterial | 0.333 0.112 DBMET02920 0.305 0.132 DBMET02923 0.276 0.154 DBMET02926 0.387 0.083 DBMET02929 0.387 0.083 DBMET02930 0.292 0.142 DBMET02931 0.379 0.087 DBMET02921 0.284 0.147 DBMET02922 0.35 0.102 DBMET02925 0.35 0.102 DBMET02924 0.321 0.12 DBMET02927 0.321 0.12 DBMET02928 0.375 0.088 DBMET02932 0.356 0.098 DBMET02933 0.356 0.098 DBMET02934 | DBMET02930 | |
| 0.241 | 0.011 | 0.256 | Topoisomerase II alpha inhibitor | 0.216 0.013 DBMET02920 0.252 0.01 DBMET02923 0.256 0.01 DBMET02926 0.245 0.01 DBMET02931 0.217 0.013 DBMET02922 0.213 0.013 DBMET02932 | DBMET02926 | |
| 0.288 | 0.058 | 0.339 | Tumour necrosis factor alpha release inhibitor | 0.289 0.058 DBMET02920 0.182 0.124 DBMET02923 0.196 0.113 DBMET02926 0.339 0.041 DBMET02929 0.339 0.041 DBMET02930 0.337 0.041 DBMET02921 0.239 0.08 DBMET02925 0.239 0.08 DBMET02924 0.254 0.073 DBMET02927 0.254 0.073 DBMET02928 0.177 0.128 DBMET02933 0.177 0.128 DBMET02934 | DBMET02930 | |
| 0.237 | 0.014 | 0.237 | Farnesoid X receptor antagonist | 0.225 0.016 DBMET02920 0.229 0.015 DBMET02923 0.215 0.018 DBMET02926 0.226 0.015 DBMET02929 0.226 0.015 DBMET02930 0.197 0.022 DBMET02931 0.214 0.018 DBMET02921 0.187 0.026 DBMET02922 0.218 0.017 DBMET02925 0.218 0.017 DBMET02924 0.204 0.02 DBMET02927 0.204 0.02 DBMET02928 0.206 0.02 DBMET02932 0.187 0.026 DBMET02933 0.187 0.026 DBMET02934 | ||
| 0.244 | 0.025 | 0.327 | Monophenol monooxygenase inhibitor | 0.238 0.026 DBMET02920 0.228 0.027 DBMET02923 0.263 0.022 DBMET02926 0.308 0.017 DBMET02929 0.308 0.017 DBMET02930 0.101 0.075 DBMET02931 0.301 0.018 DBMET02921 0.098 0.077 DBMET02922 0.292 0.019 DBMET02925 0.292 0.019 DBMET02924 0.327 0.015 DBMET02927 0.327 0.015 DBMET02928 0.134 0.053 DBMET02933 0.134 0.053 DBMET02934 | DBMET02928 | |
| 0.234 | 0.015 | 0.234 | Interleukin 4 antagonist | 0.22 0.018 DBMET02920 0.221 0.018 DBMET02923 0.208 0.02 DBMET02926 0.151 0.049 DBMET02929 0.151 0.049 DBMET02930 0.184 0.028 DBMET02931 0.145 0.054 DBMET02921 0.175 0.032 DBMET02922 0.142 0.058 DBMET02925 0.142 0.058 DBMET02924 0.133 0.068 DBMET02927 0.133 0.068 DBMET02928 0.189 0.026 DBMET02932 0.113 0.096 DBMET02933 0.113 0.096 DBMET02934 | ||
| 0.221 | 0.009 | 0.242 | Antineoplastic alkaloid | 0.221 0.009 DBMET02920 0.242 0.005 DBMET02923 0.222 0.008 DBMET02926 0.216 0.01 DBMET02929 0.216 0.01 DBMET02930 0.2 0.014 DBMET02931 0.216 0.01 DBMET02921 0.201 0.014 DBMET02922 0.238 0.005 DBMET02925 0.238 0.005 DBMET02924 0.217 0.009 DBMET02927 0.217 0.009 DBMET02928 0.205 0.012 DBMET02932 0.192 0.016 DBMET02933 0.192 0.016 DBMET02934 | DBMET02923 | |
| 0.27 | 0.07 | 0.27 | DNA damaging | 0.196 0.119 DBMET02920 0.188 0.126 DBMET02923 0.236 0.089 DBMET02926 0.183 0.131 DBMET02931 0.178 0.136 DBMET02932 | ||
| 0.334 | 0.135 | 0.375 | Cyclophilin D inhibitor | 0.343 0.127 DBMET02920 0.375 0.105 DBMET02923 0.26 0.202 DBMET02926 0.31 0.154 DBMET02929 0.31 0.154 DBMET02930 0.296 0.166 DBMET02931 0.322 0.144 DBMET02921 0.309 0.155 DBMET02922 0.351 0.121 DBMET02925 0.351 0.121 DBMET02924 0.237 0.228 DBMET02927 0.237 0.228 DBMET02928 0.271 0.19 DBMET02932 0.288 0.173 DBMET02933 0.288 0.173 DBMET02934 | DBMET02923 | |
| 0.285 | 0.087 | 0.31 | Caspase 3 stimulant | 0.31 0.074 DBMET02920 0.255 0.108 DBMET02923 0.299 0.079 DBMET02926 0.24 0.121 DBMET02931 0.189 0.186 DBMET02921 0.265 0.1 DBMET02922 0.279 0.09 DBMET02932 | DBMET02920 | |
| 0.279 | 0.09 | 0.327 | Interleukin 2 agonist | 0.291 0.081 DBMET02920 0.255 0.113 DBMET02923 0.217 0.161 DBMET02926 0.318 0.062 DBMET02929 0.318 0.062 DBMET02930 0.247 0.122 DBMET02931 0.327 0.057 DBMET02921 0.262 0.106 DBMET02922 0.298 0.075 DBMET02925 0.298 0.075 DBMET02924 0.266 0.102 DBMET02927 0.266 0.102 DBMET02928 0.264 0.104 DBMET02932 0.298 0.075 DBMET02933 0.298 0.075 DBMET02934 | DBMET02921 | |
| 0.2 | 0.02 | 0.2 | Expectorant | 0.152 0.035 DBMET02920 0.124 0.048 DBMET02923 0.121 0.05 DBMET02926 0.137 0.041 DBMET02929 0.137 0.041 DBMET02930 0.108 0.06 DBMET02931 0.102 0.066 DBMET02921 0.112 0.057 DBMET02932 | ||
| 0.181 | 0.003 | 0.214 | 5-Alpha-reductase 1 inhibitor | 0.067 0.006 DBMET02920 0.058 0.007 DBMET02923 0.164 0.003 DBMET02926 0.183 0.003 DBMET02929 0.183 0.003 DBMET02930 0.214 0.003 DBMET02931 0.069 0.006 DBMET02921 0.093 0.005 DBMET02922 0.061 0.006 DBMET02925 0.061 0.006 DBMET02924 0.167 0.003 DBMET02927 0.167 0.003 DBMET02928 0.076 0.005 DBMET02932 0.208 0.003 DBMET02933 0.208 0.003 DBMET02934 | DBMET02931 | |
| 0.184 | 0.011 | 0.184 | Estrogen receptor beta antagonist | 0.148 0.016 DBMET02920 0.139 0.019 DBMET02923 0.127 0.025 DBMET02926 0.152 0.015 DBMET02929 0.152 0.015 DBMET02930 0.176 0.012 DBMET02931 0.132 0.022 DBMET02921 0.142 0.018 DBMET02922 0.125 0.027 DBMET02925 0.125 0.027 DBMET02924 0.116 0.037 DBMET02927 0.116 0.037 DBMET02928 0.144 0.017 DBMET02932 0.145 0.017 DBMET02933 0.145 0.017 DBMET02934 | ||
| 0.192 | 0.022 | 0.232 | Microtubule formation inhibitor | 0.152 0.036 DBMET02920 0.184 0.024 DBMET02923 0.169 0.029 DBMET02926 0.232 0.013 DBMET02929 0.232 0.013 DBMET02930 0.109 0.076 DBMET02931 0.19 0.022 DBMET02921 0.225 0.015 DBMET02925 0.225 0.015 DBMET02924 0.209 0.018 DBMET02927 0.209 0.018 DBMET02928 0.153 0.036 DBMET02932 0.143 0.042 DBMET02933 0.143 0.042 DBMET02934 | DBMET02930 | |
| 0.176 | 0.011 | 0.254 | Inducible nitric-oxide synthase inhibitor | 0.084 0.056 DBMET02920 0.102 0.035 DBMET02923 0.155 0.015 DBMET02926 0.254 0.005 DBMET02931 0.122 0.024 DBMET02922 0.112 0.028 DBMET02932 0.086 0.053 DBMET02933 0.086 0.053 DBMET02934 | DBMET02931 | |
| 0.166 | 0.014 | 0.208 | Toll-Like receptor 4 antagonist | 0.148 0.022 DBMET02920 0.145 0.024 DBMET02923 0.147 0.022 DBMET02926 0.208 0.005 DBMET02929 0.208 0.005 DBMET02930 0.162 0.015 DBMET02931 0.193 0.007 DBMET02921 0.143 0.025 DBMET02922 0.193 0.007 DBMET02925 0.193 0.007 DBMET02924 0.195 0.007 DBMET02927 0.195 0.007 DBMET02928 0.128 0.036 DBMET02932 0.208 0.005 DBMET02933 0.208 0.005 DBMET02934 | DBMET02934 | |
| 0.172 | 0.022 | 0.172 | Mucolytic | 0.14 0.038 DBMET02920 0.12 0.054 DBMET02923 0.111 0.064 DBMET02926 0.124 0.051 DBMET02929 0.124 0.051 DBMET02930 0.126 0.049 DBMET02931 0.096 0.083 DBMET02921 0.099 0.079 DBMET02922 0.131 0.045 DBMET02932 0.092 0.09 DBMET02933 0.092 0.09 DBMET02934 | ||
| 0.18 | 0.032 | 0.204 | DNA intercalator | 0.186 0.03 DBMET02920 0.189 0.029 DBMET02923 0.204 0.024 DBMET02926 0.162 0.038 DBMET02931 0.17 0.035 DBMET02922 0.156 0.04 DBMET02932 | DBMET02926 | |
| 0.148 | 0.004 | 0.278 | Steroid 17-alpha-hydroxylase/17,20 lyase inhibitor | 0.029 0.009 DBMET02920 0.024 0.011 DBMET02923 0.121 0.004 DBMET02926 0.149 0.004 DBMET02929 0.149 0.004 DBMET02930 0.257 0.003 DBMET02931 0.03 0.009 DBMET02921 0.048 0.006 DBMET02922 0.024 0.011 DBMET02925 0.024 0.011 DBMET02924 0.122 0.004 DBMET02927 0.122 0.004 DBMET02928 0.243 0.003 DBMET02932 0.278 0.003 DBMET02933 0.278 0.003 DBMET02934 | DBMET02934 | |
| 0.146 | 0.007 | 0.18 | Estrogen receptor beta agonist | 0.18 0.005 DBMET02920 0.077 0.015 DBMET02923 0.057 0.018 DBMET02926 0.143 0.008 DBMET02929 0.143 0.008 DBMET02930 0.13 0.009 DBMET02931 0.177 0.005 DBMET02921 0.171 0.005 DBMET02922 0.075 0.015 DBMET02925 0.075 0.015 DBMET02924 0.056 0.018 DBMET02927 0.056 0.018 DBMET02928 0.101 0.011 DBMET02932 0.128 0.009 DBMET02933 0.128 0.009 DBMET02934 | DBMET02920 | |
| 0.138 | 0.009 | 0.15 | Na+ K+ transporting ATPase inhibitor | 0.145 0.007 DBMET02920 0.128 0.012 DBMET02923 0.127 0.013 DBMET02926 0.142 0.007 DBMET02929 0.142 0.007 DBMET02930 0.13 0.012 DBMET02931 0.15 0.006 DBMET02921 0.136 0.009 DBMET02922 0.132 0.011 DBMET02925 0.132 0.011 DBMET02924 0.131 0.011 DBMET02927 0.131 0.011 DBMET02928 0.138 0.009 DBMET02932 0.136 0.009 DBMET02933 0.136 0.009 DBMET02934 | DBMET02921 | |
| 0.133 | 0.004 | 0.154 | RNA-directed RNA polymerase stimulant | 0.122 0.005 DBMET02920 0.154 0.004 DBMET02923 0.101 0.006 DBMET02926 0.127 0.005 DBMET02929 0.127 0.005 DBMET02930 0.122 0.005 DBMET02931 0.117 0.005 DBMET02921 0.111 0.005 DBMET02922 0.147 0.004 DBMET02925 0.147 0.004 DBMET02924 0.097 0.006 DBMET02927 0.097 0.006 DBMET02928 0.101 0.006 DBMET02932 0.118 0.005 DBMET02933 0.118 0.005 DBMET02934 | DBMET02923 | |
| 0.143 | 0.017 | 0.228 | Transcription factor NF kappa B stimulant | 0.143 0.017 DBMET02920 0.132 0.02 DBMET02923 0.196 0.009 DBMET02926 0.171 0.012 DBMET02929 0.171 0.012 DBMET02930 0.184 0.011 DBMET02931 0.17 0.012 DBMET02921 0.182 0.011 DBMET02922 0.159 0.014 DBMET02925 0.159 0.014 DBMET02924 0.228 0.007 DBMET02927 0.228 0.007 DBMET02928 0.187 0.01 DBMET02932 0.216 0.008 DBMET02933 0.216 0.008 DBMET02934 | DBMET02928 | |
| 0.211 | 0.089 | 0.257 | Angiogenesis stimulant | 0.255 0.067 DBMET02920 0.179 0.106 DBMET02923 0.257 0.067 DBMET02926 0.192 0.098 DBMET02929 0.192 0.098 DBMET02930 0.24 0.074 DBMET02921 0.158 0.117 DBMET02925 0.158 0.117 DBMET02924 0.241 0.074 DBMET02927 0.241 0.074 DBMET02928 | DBMET02926 | |
| 0.118 | 0.004 | 0.124 | Nitric oxide donor | 0.116 0.004 DBMET02920 0.117 0.004 DBMET02923 0.117 0.004 DBMET02926 0.099 0.009 DBMET02929 0.099 0.009 DBMET02930 0.112 0.005 DBMET02931 0.097 0.01 DBMET02921 0.11 0.005 DBMET02922 0.096 0.011 DBMET02925 0.096 0.011 DBMET02924 0.095 0.011 DBMET02927 0.095 0.011 DBMET02928 0.124 0.004 DBMET02932 0.084 0.019 DBMET02933 0.084 0.019 DBMET02934 | DBMET02932 | |
| 0.111 | 0.003 | 0.173 | Glucose-6-phosphate dehydrogenase inhibitor | 0.104 0.003 DBMET02920 0.113 0.003 DBMET02923 0.1 0.003 DBMET02926 0.057 0.008 DBMET02929 0.057 0.008 DBMET02930 0.173 0.002 DBMET02931 0.054 0.009 DBMET02921 0.154 0.002 DBMET02922 0.057 0.008 DBMET02925 0.057 0.008 DBMET02924 0.048 0.013 DBMET02927 0.048 0.013 DBMET02928 0.137 0.002 DBMET02932 0.081 0.004 DBMET02933 0.081 0.004 DBMET02934 | DBMET02931 | |
| 0.149 | 0.044 | 0.163 | Ca2+-transporting ATPase inhibitor | 0.145 0.055 DBMET02920 0.163 0.02 DBMET02923 0.161 0.023 DBMET02926 0.129 0.127 DBMET02929 0.129 0.127 DBMET02930 0.142 0.065 DBMET02931 0.139 0.079 DBMET02922 0.141 0.069 DBMET02925 0.141 0.069 DBMET02924 0.139 0.076 DBMET02927 0.139 0.076 DBMET02928 0.149 0.044 DBMET02932 | DBMET02923 | |
| 0.136 | 0.033 | 0.143 | Beta glucuronidase inhibitor | 0.118 0.048 DBMET02920 0.131 0.036 DBMET02923 0.134 0.034 DBMET02926 0.143 0.029 DBMET02929 0.143 0.029 DBMET02930 0.125 0.042 DBMET02921 0.138 0.032 DBMET02925 0.138 0.032 DBMET02924 0.141 0.03 DBMET02927 0.141 0.03 DBMET02928 0.092 0.083 DBMET02933 0.092 0.083 DBMET02934 | DBMET02930 | |
| 0.107 | 0.006 | 0.176 | Heme oxygenase stimulant | 0.103 0.007 DBMET02920 0.109 0.005 DBMET02923 0.11 0.005 DBMET02926 0.102 0.007 DBMET02929 0.102 0.007 DBMET02930 0.176 0.002 DBMET02931 0.098 0.008 DBMET02921 0.169 0.002 DBMET02922 0.104 0.006 DBMET02925 0.104 0.006 DBMET02924 0.105 0.006 DBMET02927 0.105 0.006 DBMET02928 0.161 0.002 DBMET02932 0.166 0.002 DBMET02933 0.166 0.002 DBMET02934 | DBMET02931 | |
| 0.108 | 0.008 | 0.191 | Estrogen receptor alpha agonist | 0.191 0.005 DBMET02920 0.105 0.008 DBMET02923 0.091 0.01 DBMET02926 0.107 0.008 DBMET02929 0.107 0.008 DBMET02930 0.096 0.009 DBMET02931 0.187 0.005 DBMET02921 0.172 0.005 DBMET02922 0.104 0.008 DBMET02925 0.104 0.008 DBMET02924 0.09 0.01 DBMET02927 0.09 0.01 DBMET02928 0.072 0.013 DBMET02932 0.095 0.009 DBMET02933 0.095 0.009 DBMET02934 | DBMET02920 | |
| 0.102 | 0.005 | 0.179 | 5-Alpha-reductase 2 inhibitor | 0.037 0.008 DBMET02920 0.033 0.009 DBMET02923 0.134 0.004 DBMET02926 0.146 0.004 DBMET02929 0.146 0.004 DBMET02930 0.126 0.004 DBMET02931 0.086 0.005 DBMET02921 0.059 0.007 DBMET02922 0.076 0.006 DBMET02925 0.076 0.006 DBMET02924 0.179 0.003 DBMET02927 0.179 0.003 DBMET02928 0.045 0.007 DBMET02932 0.166 0.004 DBMET02933 0.166 0.004 DBMET02934 | DBMET02928 | |
| 0.163 | 0.066 | 0.191 | Melanin inhibitor | 0.153 0.077 DBMET02920 0.168 0.061 DBMET02923 0.182 0.05 DBMET02926 0.17 0.059 DBMET02929 0.17 0.059 DBMET02930 0.148 0.085 DBMET02931 0.16 0.069 DBMET02921 0.139 0.098 DBMET02922 0.175 0.055 DBMET02925 0.175 0.055 DBMET02924 0.191 0.045 DBMET02927 0.191 0.045 DBMET02928 0.143 0.092 DBMET02932 0.159 0.071 DBMET02933 0.159 0.071 DBMET02934 | DBMET02928 | |
| 0.146 | 0.051 | 0.153 | DNA polymerase I inhibitor | 0.153 0.047 DBMET02920 0.135 0.058 DBMET02923 0.148 0.05 DBMET02926 0.145 0.052 DBMET02929 0.145 0.052 DBMET02930 0.12 0.068 DBMET02931 0.152 0.048 DBMET02921 0.13 0.061 DBMET02922 0.134 0.058 DBMET02925 0.134 0.058 DBMET02924 0.147 0.051 DBMET02927 0.147 0.051 DBMET02928 0.124 0.065 DBMET02932 0.126 0.064 DBMET02933 0.126 0.064 DBMET02934 | DBMET02920 | |
| 0.105 | 0.02 | 0.107 | T cell inhibitor | 0.101 0.024 DBMET02920 0.1 0.025 DBMET02923 0.107 0.019 DBMET02926 0.084 0.052 DBMET02929 0.084 0.052 DBMET02930 0.096 0.028 DBMET02931 0.082 0.06 DBMET02921 0.093 0.033 DBMET02922 0.08 0.068 DBMET02925 0.08 0.068 DBMET02924 0.085 0.05 DBMET02927 0.085 0.05 DBMET02928 0.085 0.05 DBMET02932 | DBMET02926 | |
| 0.147 | 0.065 | 0.147 | Cytokine production inhibitor | |||
| 0.15 | 0.068 | 0.207 | Protein kinase stimulant | 0.146 0.071 DBMET02920 0.142 0.074 DBMET02923 0.185 0.048 DBMET02926 0.132 0.082 DBMET02929 0.132 0.082 DBMET02930 0.158 0.063 DBMET02931 0.127 0.085 DBMET02921 0.153 0.066 DBMET02922 0.124 0.088 DBMET02925 0.124 0.088 DBMET02924 0.166 0.058 DBMET02927 0.166 0.058 DBMET02928 0.207 0.039 DBMET02932 0.149 0.069 DBMET02933 0.149 0.069 DBMET02934 | DBMET02932 | |
| 0.17 | 0.095 | 0.17 | Non-steroidal antiinflammatory agent | 0.14 0.13 DBMET02926 | ||
| 0.078 | 0.005 | 0.094 | Estrone sulfatase inhibitor | 0.055 0.007 DBMET02920 0.063 0.006 DBMET02923 0.043 0.008 DBMET02926 0.06 0.006 DBMET02929 0.06 0.006 DBMET02930 0.094 0.005 DBMET02931 0.044 0.008 DBMET02921 0.062 0.006 DBMET02922 0.05 0.007 DBMET02925 0.05 0.007 DBMET02924 0.03 0.01 DBMET02927 0.03 0.01 DBMET02928 0.046 0.008 DBMET02932 0.065 0.005 DBMET02933 0.065 0.005 DBMET02934 | DBMET02931 | |
| 0.183 | 0.123 | 0.261 | Peptidyltransferase inhibitor | 0.213 0.083 DBMET02923 0.164 0.159 DBMET02926 0.236 0.061 DBMET02929 0.236 0.061 DBMET02930 0.208 0.089 DBMET02921 0.261 0.043 DBMET02925 0.261 0.043 DBMET02924 0.222 0.074 DBMET02927 0.222 0.074 DBMET02928 0.183 0.123 DBMET02932 0.211 0.086 DBMET02933 0.211 0.086 DBMET02934 | DBMET02924 | |
| 0.217 | 0.158 | 0.299 | Antithrombotic | 0.217 0.158 DBMET02920 0.203 0.173 DBMET02926 0.299 0.089 DBMET02929 0.299 0.089 DBMET02930 0.299 0.088 DBMET02921 0.24 0.134 DBMET02925 0.24 0.134 DBMET02924 0.286 0.098 DBMET02927 0.286 0.098 DBMET02928 | DBMET02921 | |
| 0.071 | 0.015 | 0.077 | Estradiol 17 beta-dehydrogenase inhibitor | 0.076 0.014 DBMET02920 0.077 0.014 DBMET02923 0.039 0.032 DBMET02926 0.071 0.015 DBMET02929 0.071 0.015 DBMET02930 0.047 0.026 DBMET02931 0.076 0.014 DBMET02921 0.051 0.024 DBMET02922 0.077 0.014 DBMET02925 0.077 0.014 DBMET02924 0.039 0.032 DBMET02927 0.039 0.032 DBMET02928 0.048 0.026 DBMET02933 0.048 0.026 DBMET02934 | DBMET02924 | |
| 0.093 | 0.039 | 0.093 | Glycine receptor antagonist | 0.076 0.063 DBMET02929 0.076 0.063 DBMET02930 0.081 0.055 DBMET02932 | ||
| 0.203 | 0.166 | 0.203 | Angiogenesis inhibitor | 0.199 0.17 DBMET02931 | ||
| 0.054 | 0.023 | 0.054 | Microtubule stabilization | 0.05 0.029 DBMET02920 0.051 0.027 DBMET02923 0.053 0.024 DBMET02926 0.053 0.024 DBMET02929 0.053 0.024 DBMET02930 0.048 0.031 DBMET02921 0.05 0.029 DBMET02925 0.05 0.029 DBMET02924 0.052 0.025 DBMET02927 0.052 0.025 DBMET02928 0.047 0.032 DBMET02932 | ||
| 0.074 | 0.048 | 0.074 | Glycine receptor agonist | 0.069 0.057 DBMET02926 | ||
| 0.028 | 0.005 | 0.031 | Progesterone receptor B antagonist | 0.018 0.016 DBMET02920 0.021 0.011 DBMET02926 0.026 0.006 DBMET02929 0.026 0.006 DBMET02930 0.031 0.005 DBMET02931 0.02 0.013 DBMET02922 0.02 0.013 DBMET02927 0.02 0.013 DBMET02928 0.023 0.008 DBMET02932 0.028 0.005 DBMET02933 0.028 0.005 DBMET02934 | DBMET02931 | |
| 0.128 | 0.106 | 0.157 | Adenylate cyclase stimulant | 0.129 0.103 DBMET02920 0.133 0.094 DBMET02923 0.137 0.087 DBMET02926 0.149 0.065 DBMET02929 0.149 0.065 DBMET02930 0.149 0.064 DBMET02921 0.153 0.057 DBMET02925 0.153 0.057 DBMET02924 0.157 0.052 DBMET02927 0.157 0.052 DBMET02928 | DBMET02928 | |
| 0.084 | 0.063 | 0.097 | Ornithine decarboxylase inhibitor | 0.092 0.054 DBMET02929 0.092 0.054 DBMET02930 0.086 0.06 DBMET02931 0.097 0.048 DBMET02933 0.097 0.048 DBMET02934 | DBMET02934 | |
| 0.055 | 0.036 | 0.06 | 3(or 17)beta-hydroxysteroid dehydrogenase inhibitor | 0.06 0.03 DBMET02931 0.052 0.04 DBMET02922 0.048 0.046 DBMET02933 0.048 0.046 DBMET02934 | DBMET02931 | |
| 0.033 | 0.015 | 0.036 | 11-Beta-hydroxysteroid dehydrogenase 2 inhibitor | 0.027 0.019 DBMET02926 0.034 0.014 DBMET02931 0.036 0.013 DBMET02932 | DBMET02932 | |
| 0.046 | 0.034 | 0.048 | Adenosine deaminase inhibitor | 0.048 0.032 DBMET02920 | DBMET02920 | |
| 0.014 | 0.006 | 0.014 | 3 Beta-hydroxy-delta 5-steroid dehydrogenase inhibitor | 0.013 0.007 DBMET02920 0.013 0.007 DBMET02923 0.013 0.007 DBMET02926 0.013 0.007 DBMET02929 0.013 0.007 DBMET02930 0.014 0.005 DBMET02931 0.012 0.008 DBMET02921 0.014 0.006 DBMET02922 0.013 0.008 DBMET02925 0.013 0.008 DBMET02924 0.012 0.009 DBMET02927 0.012 0.009 DBMET02928 0.013 0.008 DBMET02932 0.013 0.006 DBMET02933 0.013 0.006 DBMET02934 | ||
| 0.027 | 0.021 | 0.034 | Hedgehog signaling activator | 0.034 0.007 DBMET02923 0.032 0.01 DBMET02925 0.032 0.01 DBMET02924 | DBMET02923 | |
| 0.016 | 0.013 | 0.018 | Vitamin D receptor agonist | 0.018 0.009 DBMET02929 0.018 0.009 DBMET02930 0.015 0.014 DBMET02931 0.016 0.012 DBMET02921 0.016 0.012 DBMET02927 0.016 0.012 DBMET02928 0.016 0.013 DBMET02932 0.018 0.009 DBMET02933 0.018 0.009 DBMET02934 | DBMET02934 | |
| 0.046 | 0.044 | 0.053 | Protein 50S ribosomal subunit inhibitor | 0.049 0.041 DBMET02929 0.049 0.041 DBMET02930 0.053 0.037 DBMET02932 0.046 0.045 DBMET02933 0.046 0.045 DBMET02934 | DBMET02932 | |
| 0.032 | 0.03 | 0.032 | Tubulin agonist | |||
| 0.021 | 0.02 | 0.025 | Protein 30S ribosomal subunit inhibitor | 0.023 0.018 DBMET02923 0.023 0.018 DBMET02929 0.023 0.018 DBMET02930 0.022 0.019 DBMET02921 0.025 0.016 DBMET02925 0.025 0.016 DBMET02924 | DBMET02924 | |
| 0.08 | 0.08 | 0.099 | Breast cancer-resistant protein inhibitor | 0.099 0.056 DBMET02926 | DBMET02926 | |
| 0.04 | 0.041 | 0.061 | 11-Beta-hydroxysteroid dehydrogenase 1 inhibitor | 0.043 0.037 DBMET02926 0.061 0.022 DBMET02931 0.059 0.023 DBMET02922 0.044 0.035 DBMET02932 | DBMET02931 | |
| 0.008 | 0.01 | 0.01 | Progesterone receptor A antagonist | 0.01 0.006 DBMET02931 | DBMET02931 | |
| 0.082 | 0.088 | 0.171 | Topoisomerase I inhibitor | 0.171 0.034 DBMET02920 0.085 0.084 DBMET02923 0.102 0.069 DBMET02926 0.092 0.077 DBMET02921 0.158 0.038 DBMET02922 0.091 0.078 DBMET02932 | DBMET02920 | |
| 0.135 | 0.141 | 0.165 | Phospholipase C inhibitor | 0.139 0.13 DBMET02931 0.165 0.08 DBMET02932 | DBMET02932 | |
| 0.019 | 0.025 | 0.02 | Vitamin D receptor antagonist | 0.02 0.019 DBMET02925 0.02 0.019 DBMET02924 | DBMET02924 | |
| 0.026 | 0.033 | 0.042 | Estradiol 17 beta-dehydrogenase 3 inhibitor | 0.042 0.015 DBMET02923 0.03 0.025 DBMET02931 0.034 0.02 DBMET02925 0.034 0.02 DBMET02924 | DBMET02923 | |
| 0.028 | 0.04 | 0.034 | Farnesoid X receptor agonist | 0.034 0.031 DBMET02920 | DBMET02920 | |
| 0.085 | 0.1 | 0.118 | Adenylate cyclase inhibitor | 0.098 0.086 DBMET02920 0.101 0.084 DBMET02923 0.101 0.083 DBMET02929 0.101 0.083 DBMET02930 0.115 0.071 DBMET02921 0.118 0.069 DBMET02925 0.118 0.069 DBMET02924 | DBMET02924 | |
| 0.115 | 0.13 | 0.121 | Growth hormone agonist | 0.121 0.12 DBMET02923 0.121 0.12 DBMET02926 | DBMET02926 | |
| 0.053 | 0.098 | 0.062 | Prolactin release inhibitor | 0.062 0.042 DBMET02920 0.06 0.052 DBMET02921 | DBMET02920 | |
| 0.025 | 0.07 | 0.034 | Antibiotic Aminoglycoside-like | 0.034 0.029 DBMET02925 0.034 0.029 DBMET02924 | DBMET02924 | |
| 0.03 | 0.076 | 0.172 | Beta tubulin antagonist | 0.161 0.011 DBMET02920 0.141 0.013 DBMET02921 0.172 0.01 DBMET02922 | DBMET02922 | |
| 0.07 | 0.119 | 0.091 | Protein-tyrosine phosphatase 1B inhibitor | 0.091 0.088 DBMET02932 | DBMET02932 | |
| 0.031 | 0.081 | 0.276 | Alpha tubulin antagonist | 0.258 0.005 DBMET02920 0.247 0.005 DBMET02921 0.276 0.004 DBMET02922 | DBMET02922 | |
| 0.127 | 0.181 | 0.15 | Free radical scavenger | 0.15 0.145 DBMET02929 0.15 0.145 DBMET02930 | DBMET02930 | |
| 0.064 | 0.141 | 0.103 | Nitric-oxide synthase inhibitor | 0.103 0.055 DBMET02931 | DBMET02931 | |
| 0.028 | 0.121 | 0.057 | Alpha-mannosidase inhibitor | 0.057 0.031 DBMET02921 | DBMET02921 | |
| 0.063 | 0.159 | 0.101 | Amylase inhibitor | 0.101 0.096 DBMET02920 | DBMET02920 | |
| 0.146 | 0.243 | 0.262 | Immunomodulator | 0.262 0.106 DBMET02926 0.204 0.159 DBMET02927 0.204 0.159 DBMET02928 | DBMET02926 | |
| 0.048 | 0.157 | 0.076 | GABA A receptor agonist | 0.076 0.071 DBMET02931 | DBMET02931 | |
| 0.058 | 0.179 | 0.114 | Ca(v)3.1 blocker | 0.114 0.013 DBMET02931 0.081 0.057 DBMET02922 0.091 0.034 DBMET02932 0.104 0.019 DBMET02933 0.104 0.019 DBMET02934 | DBMET02931 | |
| 0.093 | 0.225 | 0.172 | Hypolipemic | 0.148 0.139 DBMET02929 0.148 0.139 DBMET02930 0.172 0.117 DBMET02925 0.172 0.117 DBMET02924 0.159 0.128 DBMET02933 0.159 0.128 DBMET02934 | DBMET02924 | |
| 0.016 | 0.156 | 0.043 | Mannosidase inhibitor | 0.043 0.036 DBMET02921 | DBMET02921 | |
| 0.052 | 0.192 | 0.175 | Tubulin antagonist | 0.169 0.049 DBMET02920 0.135 0.067 DBMET02921 0.175 0.047 DBMET02922 | DBMET02922 | |
| 0.052 | 0.215 | 0.11 | ABCA1 expression enhancer | 0.11 0.039 DBMET02920 0.108 0.041 DBMET02921 0.105 0.044 DBMET02922 | DBMET02920 | |
| 0.047 | 0.212 | 0.095 | GABA receptor agonist | 0.095 0.084 DBMET02931 | DBMET02931 | |
| 0.076 | 0.373 | 0.188 | Hypoglycemic | 0.188 0.124 DBMET02921 | DBMET02921 | |
| 0.103 | 0.599 | 0.339 | Calcium channel L-type activator | 0.339 0.126 DBMET02921 0.253 0.202 DBMET02927 0.253 0.202 DBMET02928 0.262 0.193 DBMET02933 0.262 0.193 DBMET02934 | DBMET02921 | Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |